Zkusit zdarma
Gossamer Bio, Inc.

Gossamer Bio, Inc.

GOSS
Cena:
$ 0.21
+0.01 (5.00%)
Valuace
70
Růst
30
Zdraví
50
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
GOSS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026

GOSS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026

12:20 23-05-2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff...

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- HBSS

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- HBSS

10:00 23-05-2026

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failu...

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- HBSS

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- HBSS

9:43 23-05-2026

GOSS Investors with Losses Encouraged to Contact the Firm Before June 1st Deadline SAN FRANCISCO, Ma...

GOSS Investor Alert - Gossamer Bio, Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

GOSS Investor Alert - Gossamer Bio, Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

18:54 22-05-2026

SAN DIEGO, May 22, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was fi...

Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

15:00 22-05-2026

Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Laws...

Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

14:51 22-05-2026

LOS ANGELES, May 22, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors...

GOSS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026

GOSS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026

10:59 22-05-2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff...

GOSSAMER DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GOSS

GOSSAMER DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GOSS

23:30 21-05-2026

New York, New York--(Newsfile Corp. - May 21, 2026) - WHY: Rosen Law Firm, a global investor rights...

GOSSAMER DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

GOSSAMER DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

16:39 21-05-2026

NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, r...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines - GOSS

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines - GOSS

15:10 21-05-2026

NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been ...

Bronstein, Gewirtz & Grossman LLC Urges Gossamer Bio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Gossamer Bio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

12:00 21-05-2026

New York, New York--(Newsfile Corp. - May 21, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nation...

Bronstein, Gewirtz & Grossman LLC Urges Gossamer Bio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Gossamer Bio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

12:00 21-05-2026

NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz and Grossman, LLC, a nationally recogn...

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

10:02 21-05-2026

LOS ANGELES, May 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights li...

GOSSAMER BIO, INC. (GOSS) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by June 1, 2026

GOSSAMER BIO, INC. (GOSS) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by June 1, 2026

9:51 21-05-2026

Philadelphia, Pennsylvania--(Newsfile Corp. - May 21, 2026) - National plaintiffs' law firm Berger M...

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- HBSS

Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure- HBSS

9:00 21-05-2026

GOSS Investors with Losses Encouraged to Contact the Firm Before June 1st Deadline SAN FRANCISCO, Ma...

GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Placebo Response Risks: SueWallSt

GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Placebo Response Risks: SueWallSt

9:00 21-05-2026

The Red Flags: What Insiders Allegedly Knew Before Shareholders Did NEW YORK, May 21, 2026 /PRNewswi...

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOSS

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOSS

23:30 20-05-2026

New York, New York--(Newsfile Corp. - May 20, 2026) - WHY: Rosen Law Firm, a global investor rights ...

GOSS 12-DAY DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

GOSS 12-DAY DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

17:18 20-05-2026

San Francisco, California--(Newsfile Corp. - May 20, 2026) - A securities class action lawsuit has b...

Robbins LLP Reminds GOSS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Gossamer Bio, Inc.

Robbins LLP Reminds GOSS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Gossamer Bio, Inc.

16:08 20-05-2026

SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action wa...

DEADLINE ALERT: Gossamer Bio (GOSS) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before June 1, 2026 Securities Class Action Deadline

DEADLINE ALERT: Gossamer Bio (GOSS) Investors Who Suffered Losses Encouraged to Contact Faruqi & Faruqi Before June 1, 2026 Securities Class Action Deadline

10:23 20-05-2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff...

close

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

08-01-2026
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOPHARMACEUTI...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

09-12-2025
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOPHARMACEUTI...
Více zde

GOSSAMER BIO TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

24-11-2025
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOPHARMACEUTI...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

07-11-2025
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOPHARMACEUTI...
Více zde

GOSSAMER BIO TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

07-11-2025
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOP...
Více zde

GOSSAMER BIO ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

05-11-2025
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOP...
Více zde

RESPIRA THERAPEUTICS ENTERS INTO AGREEMENT WITH GOSSAMER BIO (GOSSAMER) GRANTING GOSSAMER OPTION TO ACQUIRE RESPIRA FROM SAMSARA BIOCAPITAL

25-09-2025
- TRANSACTION DESIGNED TO ACCELERATE DEVELOPMENT OF RT234 (VARDENAFIL INHALATION POWDER), AN INVESTI...
Více zde

GOSSAMER BIO ENTERS INTO OPTION AGREEMENT TO ACQUIRE RESPIRA THERAPEUTICS AND ITS LEAD CANDIDATE, RT234, AN INHALED, ON‑DEMAND VARDENAFIL FOR PULMONARY HYPERTENSION

25-09-2025
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOP...
Více zde

GOSSAMER BIO ANNOUNCES PRESENTATIONS AT THE EUROPEAN RESPIRATORY SOCIETY (ERS) CONGRESS 2025

22-09-2025
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--GOSSAMER BIO, INC. (NASDAQ: GOSS), A CLINICAL-STAGE BIOPHARMAC...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

10-09-2025
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOPHARMACEUTI...
Více zde

GOSSAMER BIO TO PRESENT AT UPCOMING INVESTOR CONFERENCES

29-08-2025
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOPHARMACEUTI...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

07-08-2025
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOPHARMACEUTI...
Více zde

GOSSAMER BIO ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

05-08-2025
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOP...
Více zde

GOSSAMER BIO ANNOUNCES COMPLETION OF ENROLLMENT IN REGISTRATIONAL PHASE 3 PROSERA STUDY FOR THE TREATMENT OF PAH

16-06-2025
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOP...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

06-06-2025
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOPHARMACEUTI...
Více zde

GOSSAMER BIO ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE, INCLUDING CLOSURE OF NEW PATIENT SCREENING IN PHASE 3 PROSERA STUDY

15-05-2025
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOP...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

07-05-2025
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOP...
Více zde

GOSSAMER BIO TO PRESENT PRECLINICAL DATA AT THE AMERICAN THORACIC SOCIETY (ATS) 2025 INTERNATIONAL CONFERENCE

07-05-2025
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--GOSSAMER BIO, INC. (NASDAQ: GOSS), A CLINICAL-STAGE BIOPHARMAC...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

08-04-2025
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOPHARMACEUTI...
Více zde

GOSSAMER BIO ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

13-03-2025
SAN DIEGO--(BUSINESS WIRE)---- $GOSS--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOP...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

07-03-2025
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A LATE-STAGE, CLINICAL BIOPHARMACEUTI...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

07-02-2025
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A CLINICAL-STAGE BIOPHARMACEUTICAL CO...
Více zde

GOSSAMER BIO PRESENTED CLINICAL AND PRECLINICAL DATA AT THE PULMONARY VASCULAR RESEARCH INSTITUTE 2025 ANNUAL CONGRESS

03-02-2025
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A CLINICAL-STAGE BIOPHARMACEUTICAL CO...
Více zde

GOSSAMER BIO TO PRESENT CLINICAL AND PRECLINICAL DATA AT THE PULMONARY VASCULAR RESEARCH INSTITUTE 2025 ANNUAL CONGRESS

28-01-2025
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A CLINICAL-STAGE BIOPHARMACEUTICAL CO...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

07-01-2025
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A CLINICAL-STAGE BIOPHARMACEUTICAL CO...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

11-11-2024
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A CLINICAL-STAGE BIOPHARMACEUTICAL CO...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

07-10-2024
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A CLINICAL-STAGE BIOPHARMACEUTICAL CO...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

07-06-2024
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A CLINICAL-STAGE BIOPHARMACEUTICAL CO...
Více zde

GOSSAMER BIO TO PROVIDE UPDATED SERALUTINIB TORREY OPEN-LABEL EXTENSION DATA AT THE AMERICAN THORACIC SOCIETY 2024 INTERNATIONAL CONFERENCE

14-05-2024
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A CLINICAL-STAGE BIOPHARMACEUTICAL CO...
Více zde

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

10-05-2024
SAN DIEGO--(BUSINESS WIRE)--GOSSAMER BIO, INC. (NASDAQ: GOSS), A CLINICAL-STAGE BIOPHARMACEUTICAL CO...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-11-05 00:00:008-KStáhnout
2025-11-05 00:00:0010-QStáhnout
2025-09-25 01:00:008-KStáhnout
2025-09-25 00:00:008-KStáhnout
2025-08-05 01:00:008-KStáhnout
2025-08-05 01:00:0010-QStáhnout
2025-08-05 00:00:008-KStáhnout
2025-08-05 00:00:0010-QStáhnout
2025-06-25 01:00:008-KStáhnout
2025-06-25 00:00:008-KStáhnout
2025-06-16 01:00:008-KStáhnout
2025-06-16 00:00:008-KStáhnout
2025-05-15 01:00:008-KStáhnout
2025-05-15 01:00:0010-QStáhnout
2025-05-15 00:00:008-KStáhnout
2025-05-15 00:00:0010-QStáhnout
2025-03-13 00:00:008-KStáhnout
2025-03-13 00:00:0010-KStáhnout
2025-03-12 23:00:008-KStáhnout
2025-03-12 23:00:0010-KStáhnout
2025-02-19 00:00:008-KStáhnout
2025-02-18 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-09-13 01:00:008-KStáhnout
2024-09-13 00:00:008-KStáhnout
2024-08-12 01:00:008-KStáhnout
2024-08-12 01:00:0010-QStáhnout
2024-08-12 00:00:008-KStáhnout
2024-08-12 00:00:0010-QStáhnout
2024-07-18 01:00:008-KStáhnout
2024-07-18 00:00:008-KStáhnout
2024-06-10 01:00:008-KStáhnout
2024-06-10 00:00:008-KStáhnout
2024-05-24 01:00:008-KStáhnout
2024-05-24 00:00:008-KStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:008-KStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-05-06 01:00:008-KStáhnout
2024-05-06 00:00:008-KStáhnout
2024-03-12 00:00:008-KStáhnout
2024-03-11 23:00:008-KStáhnout
2024-03-05 00:00:008-KStáhnout
2024-03-05 00:00:0010-KStáhnout
2024-03-04 23:00:008-KStáhnout
2024-03-04 23:00:0010-KStáhnout
2024-03-04 00:00:008-KStáhnout
2024-03-03 23:00:008-KStáhnout
2023-11-29 00:00:008-KStáhnout
2023-11-28 23:00:008-KStáhnout
2023-11-27 00:00:008-KStáhnout
2023-11-26 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-10-20 01:00:008-KStáhnout
2023-10-20 00:00:008-KStáhnout
2023-09-07 01:00:008-KStáhnout
2023-09-07 00:00:008-KStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-07-20 01:00:008-KStáhnout
2023-07-20 00:00:008-KStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-04-03 01:00:008-KStáhnout
2023-04-03 00:00:008-KStáhnout
2023-03-17 00:00:008-KStáhnout
2023-03-17 00:00:0010-KStáhnout
2023-03-16 23:00:008-KStáhnout
2023-03-16 23:00:0010-KStáhnout
2022-12-06 00:00:008-KStáhnout
2022-12-05 23:00:008-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-08-09 01:00:008-KStáhnout
2022-08-09 01:00:0010-QStáhnout
2022-08-09 00:00:008-KStáhnout
2022-08-09 00:00:0010-QStáhnout
2022-07-13 01:00:008-KStáhnout
2022-07-13 00:00:008-KStáhnout
2022-06-10 01:00:008-KStáhnout
2022-06-10 00:00:008-KStáhnout
2022-05-10 01:00:008-KStáhnout
2022-05-10 01:00:0010-QStáhnout
2022-05-10 00:00:008-KStáhnout
2022-05-10 00:00:0010-QStáhnout
2022-04-25 01:00:008-KStáhnout
2022-04-25 00:00:008-KStáhnout
2022-03-03 00:00:008-KStáhnout
2022-03-03 00:00:0010-KStáhnout
2022-03-02 23:00:008-KStáhnout
2022-03-02 23:00:0010-KStáhnout
2021-11-08 00:00:008-KStáhnout
2021-11-08 00:00:0010-QStáhnout
2021-11-07 23:00:008-KStáhnout
2021-11-07 23:00:0010-QStáhnout
2021-10-12 01:00:008-KStáhnout
2021-10-12 00:00:008-KStáhnout
2021-09-21 01:00:008-KStáhnout
2021-09-21 00:00:008-KStáhnout
2021-08-09 01:00:008-KStáhnout
2021-08-09 01:00:0010-QStáhnout
2021-08-09 00:00:008-KStáhnout
2021-08-09 00:00:0010-QStáhnout
2021-06-14 01:00:008-KStáhnout
2021-06-14 00:00:008-KStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:008-KStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-04-20 01:00:008-KStáhnout
2021-04-20 00:00:008-KStáhnout
2021-02-26 00:00:0010-KStáhnout
2021-02-25 23:00:0010-KStáhnout
2021-02-25 00:00:008-KStáhnout
2021-02-24 23:00:008-KStáhnout
2020-11-17 00:00:008-KStáhnout
2020-11-16 23:00:008-KStáhnout
2020-11-10 00:00:008-KStáhnout
2020-11-10 00:00:0010-QStáhnout
2020-11-09 23:00:008-KStáhnout
2020-11-09 23:00:0010-QStáhnout
2020-10-13 01:00:008-KStáhnout
2020-10-13 00:00:008-KStáhnout
2020-08-11 01:00:008-KStáhnout
2020-08-11 01:00:0010-QStáhnout
2020-08-11 00:00:008-KStáhnout
2020-08-11 00:00:0010-QStáhnout
2020-07-02 01:00:008-KStáhnout
2020-07-02 00:00:008-KStáhnout
2020-06-18 01:00:008-KStáhnout
2020-06-18 00:00:008-KStáhnout
2020-05-21 01:00:008-KStáhnout
2020-05-21 00:00:008-KStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 01:00:0010-QStáhnout
2020-05-12 00:00:008-KStáhnout
2020-05-12 00:00:0010-QStáhnout
2020-03-24 00:00:008-KStáhnout
2020-03-24 00:00:0010-KStáhnout
2020-03-23 23:00:008-KStáhnout
2020-03-23 23:00:0010-KStáhnout
2020-01-13 00:00:008-KStáhnout
2020-01-12 23:00:008-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-09-13 01:00:008-KStáhnout
2019-09-13 00:00:008-KStáhnout
2019-08-08 01:00:008-KStáhnout
2019-08-08 01:00:0010-QStáhnout
2019-08-08 00:00:008-KStáhnout
2019-08-08 00:00:0010-QStáhnout
2019-06-11 01:00:008-KStáhnout
2019-06-11 00:00:008-KStáhnout
2019-05-30 01:00:008-KStáhnout
2019-05-30 00:00:008-KStáhnout
2019-05-14 01:00:008-KStáhnout
2019-05-14 01:00:0010-QStáhnout
2019-05-14 00:00:008-KStáhnout
2019-05-14 00:00:0010-QStáhnout
2019-05-03 01:00:008-KStáhnout
2019-05-03 00:00:008-KStáhnout
2019-03-22 00:00:008-KStáhnout
2019-03-22 00:00:0010-KStáhnout
2019-03-21 23:00:008-KStáhnout
2019-03-21 23:00:0010-KStáhnout
2019-03-11 00:00:008-KStáhnout
2019-03-10 23:00:008-KStáhnout
2019-02-12 00:00:008-KStáhnout
2019-02-11 23:00:008-KStáhnout
preloader